ETFIQData as of Nov 18, 2026. · etfiq.com/funds/psch

PSCH Fact Sheet: Invesco S&P SmallCap Health Care ETF

Share
$56.12
close, Nov 18, 2026

Over the year to Nov 18, 2026, PSCH returned +33.8% in total and charged 0.29% a year.

1-year total return
+33.8%
to Nov 18, 2026
Expense ratio
0.29%
a year
Net assets
$186m
on Nov 17, 2026
Net flow, last 5 trading days
+$5.1m
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

PSCH $13,375 +33.8% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+6.9%
3 months−0.2%
Year to date+27.4%
1 year+33.8%
3 years+50.3%
5 years−7.4%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
TG Therapeutics Inc4.89%
Protagonist Therapeutics Inc4.44%
Alkermes PLC4.19%
Teleflex Inc3.73%
Supernus Inc3.31%
Ligand Pharmaceuticals Inc3.22%
RadNet Inc2.92%
Merit Medical Systems Inc2.77%
PTC Therapeutics Inc2.77%
Concentra Group Holdings Parent Inc2.76%

PSCH top ten by weight, 35.0% of the fund, of its 69 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P SmallCap 600 Capped Health Care Index · First traded Apr 7, 2010 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, PSCH Fact Sheet: Invesco S&P SmallCap Health Care ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/psch/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/psch.